- Home
- ITRM vs CNF Comparison
ITRM vs CNF Comparison
Compare ITRM & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- CNF
- Stock Information
- Founded
- ITRM 2015
- CNF 1999
- Country
- ITRM Ireland
- CNF China
- Employees
- ITRM N/A
- CNF N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- CNF Finance: Consumer Services
- Sector
- ITRM Health Care
- CNF Finance
- Exchange
- ITRM Nasdaq
- CNF Nasdaq
- Market Cap
- ITRM 40.0M
- CNF 34.1M
- IPO Year
- ITRM 2018
- CNF 2018
- Fundamental
- Price
- ITRM $1.01
- CNF $0.61
- Analyst Decision
- ITRM Strong Buy
- CNF
- Analyst Count
- ITRM 2
- CNF 0
- Target Price
- ITRM $7.00
- CNF N/A
- AVG Volume (30 Days)
- ITRM 481.0K
- CNF 310.6K
- Earning Date
- ITRM 08-13-2025
- CNF 04-30-2025
- Dividend Yield
- ITRM N/A
- CNF N/A
- EPS Growth
- ITRM N/A
- CNF N/A
- EPS
- ITRM N/A
- CNF 0.08
- Revenue
- ITRM N/A
- CNF $85,661,735.00
- Revenue This Year
- ITRM N/A
- CNF $252.34
- Revenue Next Year
- ITRM $270.19
- CNF N/A
- P/E Ratio
- ITRM N/A
- CNF $8.08
- Revenue Growth
- ITRM N/A
- CNF N/A
- 52 Week Low
- ITRM $0.81
- CNF $0.37
- 52 Week High
- ITRM $3.02
- CNF $2.84
- Technical
- Relative Strength Index (RSI)
- ITRM 51.14
- CNF 57.37
- Support Level
- ITRM $0.93
- CNF $0.42
- Resistance Level
- ITRM $1.06
- CNF $0.77
- Average True Range (ATR)
- ITRM 0.05
- CNF 0.08
- MACD
- ITRM 0.01
- CNF 0.02
- Stochastic Oscillator
- ITRM 34.78
- CNF 54.29
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.